Viasox, a renowned brand for its high-quality EasyStretch™ diabetic socks, is dedicated to addressing the alarming prevalence of lower limb amputations among individuals with Type 2 diabetes. Through in-depth research from reputable sources like the National Center for Biotechnology Information (NCBI) and BMJ, Viasox emphasizes the urgent need for improved management strategies to prevent diabetic foot complications.

Studies reveal that factors such as prolonged hyperglycemia, peripheral neuropathy, and peripheral artery disease (PAD) significantly increase the risk of amputations in diabetic patients. Viasox advocates for regular foot inspections, proper foot hygiene, protective footwear, and maintaining optimal blood sugar levels as preventive measures. Additionally, early detection and comprehensive foot care programs play a vital role in reducing the incidence of foot ulcers and subsequent amputations by up to 50%.

By offering innovative solutions and raising awareness about diabetic foot care, Viasox aims to empower individuals with Type 2 diabetes to proactively manage their health and prevent severe complications.